Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Opinion in Oncology|September 11, 2024
Lung cancer screening in never smokersGillianne G Y Lai, Daniel S W Tan
Cancer Treatment Reviews|September 15, 2022
Refining patient selection of MET-activated non-small cell lung cancer through biomarker precisionGillianne G Y Lai, Robin Guo, Alexander Drilon, et al.
Nature Reviews. Clinical Oncology|November 29, 2017
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesAlexander Drilon, Zishuo I Hu, Gillianne G Y Lai, et al.
Nature Reviews. Clinical Oncology|November 15, 2017
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesAlexander Drilon, Zishuo I Hu, Gillianne G Y Lai, et al.
JTO Clinical and Research Reports|January 1, 2024
Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate MeasureStephanie P L Saw, Gek San Tan, Wei Chong Tan, et al.
Human Genomics|July 17, 2023
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancerNing-Yuan Lee, Melissa Hum, Sabna Zihara, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2025
EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancerStephanie P L Saw, Angela Takano, Siqin Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2022
PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancerStephanie P L Saw, Win Pin Ng, Siqin Zhou, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2024
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLCStephanie P L Saw, Yi Fen Low, Gillianne G Y Lai, et al.
JCO Precision Oncology|October 14, 2022
Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung CancerAaron C Tan, Stephanie P L Saw, Jianbin Chen, et al.
Pageof 2